MetLife Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.99M | Sell |
35,601
-1,055
| -3% | -$263K | 0.04% | 431 |
|
|
2025
Q4 | $8.83M | Sell |
36,656
-1,298
| -3% | -$332K | 0.04% | 399 |
|
|
2025
Q3 | $10.4M | Sell |
37,954
-968
| -2% | -$264K | 0.05% | 351 |
|
|
2025
Q2 | $10M | Sell |
38,922
-923
| -2% | -$220K | 0.06% | 312 |
|
|
2025
Q1 | $8.92M | Sell |
39,845
-733
| -2% | -$171K | 0.05% | 371 |
|
|
2024
Q4 | $9.28M | Buy |
40,578
+593
| +1% | +$143K | 0.05% | 285 |
|
|
2024
Q3 | $9.76M | Sell |
39,985
-1,010
| -2% | -$226K | 0.06% | 264 |
|
|
2024
Q2 | $7.85M | Buy |
40,995
+593
| +1% | +$120K | 0.05% | 307 |
|
|
2024
Q1 | $8M | Sell |
40,402
-1,247
| -3% | -$228K | 0.05% | 293 |
|
|
2023
Q4 | $7.16M | Sell |
41,649
-703
| -2% | -$108K | 0.05% | 314 |
|
|
2023
Q3 | $6.26M | Sell |
42,352
-952
| -2% | -$172K | 0.05% | 323 |
|
|
2023
Q2 | $9.46M | Sell |
43,304
-321
| -0.7% | -$71.5K | 0.07% | 233 |
|
|
2023
Q1 | $9.55M | Sell |
43,625
-340
| -0.8% | -$73.8K | 0.07% | 222 |
|
|
2022
Q4 | $9.15M | Sell |
43,965
-855
| -2% | -$188K | 0.07% | 227 |
|
|
2022
Q3 | $9.78M | Sell |
44,820
-466
| -1% | -$106K | 0.08% | 196 |
|
|
2022
Q2 | $9.49M | Sell |
45,286
-249
| -0.5% | -$53K | 0.07% | 210 |
|
|
2022
Q1 | $11M | Buy |
45,535
+13,339
| +41% | +$3.23M | 0.07% | 213 |
|
|
2021
Q4 | $8.39M | Sell |
32,196
-671
| -2% | -$174K | 0.07% | 231 |
|
|
2021
Q3 | $8.66M | Sell |
32,867
-870
| -3% | -$238K | 0.08% | 210 |
|
|
2021
Q2 | $8.32M | Sell |
33,737
-937
| -3% | -$197K | 0.07% | 226 |
|
|
2021
Q1 | $6.73M | Sell |
34,674
-520
| -1% | -$104K | 0.06% | 280 |
|
|
2020
Q4 | $7.48M | Sell |
35,194
-1,545
| -4% | -$308K | 0.07% | 238 |
|
|
2020
Q3 | $6.3M | Sell |
36,739
-1,097
| -3% | -$203K | 0.07% | 255 |
|
|
2020
Q2 | $7.26M | Buy |
37,836
+773
| +2% | +$126K | 0.08% | 202 |
|
|
2020
Q1 | $5.46M | Sell |
37,063
-1,134
| -3% | -$181K | 0.07% | 223 |
|
|
2019
Q4 | $5.92M | Sell |
38,197
-901
| -2% | -$130K | 0.06% | 287 |
|
|
2019
Q3 | $5.28M | Sell |
39,098
-427
| -1% | -$55.9K | 0.06% | 310 |
|
|
2019
Q2 | $4.82M | Sell |
39,525
-1,206
| -3% | -$134K | 0.05% | 365 |
|
|
2019
Q1 | $4.23M | Sell |
40,731
-18
| -0% | -$1.86K | 0.05% | 417 |
|
|
2018
Q4 | $4.64M | Sell |
40,749
-771
| -2% | -$82.6K | 0.06% | 314 |
|
|
2018
Q3 | $4.79M | Sell |
41,520
-499
| -1% | -$54.7K | 0.05% | 378 |
|
|
2018
Q2 | $4.35M | Sell |
42,019
-993
| -2% | -$100K | 0.05% | 371 |
|
|
2018
Q1 | $4.24M | Sell |
43,012
-894
| -2% | -$84.5K | 0.05% | 403 |
|
|
2017
Q4 | $3.72M | Buy |
+43,906
| New | +$3.63M | 0.04% | 509 |
|
Other funds holding RMD
VCM
VPM
DAM
MetLife Investment Management's RMD Position: Q1 2026 in Review
MetLife Investment Management reduced its ResMed (RMD) stake by 2.9% in Q1 2026, selling an estimated $263K and leaving 35,601 shares worth $7.99M. The position accounts for 0.04% of the portfolio, ranked #431.
MetLife Investment Management first reported a position in RMD in Q4 2017 and has held it in 34 quarters since. The position peaked at $11M in Q1 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- MetLife Investment Management held 35,601 shares of ResMed worth $7.99M as of Q1 2026.
- MetLife Investment Management sold 1,055 ResMed shares in Q1 2026, an estimated $263K.
- ResMed made up 0.04% of MetLife Investment Management's portfolio in Q1 2026, its #431 holding.
- MetLife Investment Management first reported a position in ResMed in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's ResMed position peaked at $11M in Q1 2022.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.